Results 131 to 140 of about 333,388 (343)
Pain and dyspnea control during awake fiberoptic bronchoscopy in critically ill patients: safety and efficacy of remifentanil target-controlled infusion [PDF]
, 2021 Margot Caron +15 more
openalex +1 more source
Equine trypanosomiasis, a systematic review: Disease management
Equine Veterinary Journal, EarlyView.Abstract Background Equine trypanosomiasis is a neglected protozoal disease. Objectives To answer the study question: In equines what are the effects of disease management of trypanosomiasis on disease severity (individual level) and disease prevalence (population level) compared to no intervention? Study Design Systematic review.
Alexandra G. Raftery +5 more
wiley +1 more source
Factors associated with phenotypes of dyspnea in post-COVID-19 condition: a cross-sectional study [PDF]
Maeve P. Smith +6 more
openalex +1 more source
Head &Neck, EarlyView.ABSTRACT Objective To evaluate clinical outcomes and quality of life (QOL) following hypofractionated spot‐scanning proton therapy (SSPT) for head and neck malignant mucosal melanoma (HNMM). Methods This retrospective study included 39 patients treated with SSPT (60–64 Gy[RBE] in 15–16 fractions) between 2013 and 2023.
Koichiro Nakajima +11 more
wiley +1 more source
Interactions Between Dyspnea and the Brain Processing of Nociceptive Stimuli: Experimental Air Hunger Attenuates Laser-Evoked Brain Potentials in Humans [PDF]
, 2015 Laurence Dangers +3 more
openalex +1 more source
Subglottic Stenosis After Radioactive Iodine Treatment for Graves' Disease: A Case Report
Head &Neck, EarlyView.ABSTRACT Background Subglottic stenosis (SGS) is a narrowing of the airway below the glottis and may be congenital or acquired. While prolonged intubation is the most common cause of acquired SGS, other etiologies remain incompletely understood. Methods A 37‐year‐old woman presented with a four‐year history of mild progressive stridor, dysphonia, and ...
Claire Ettlin +3 more
wiley +1 more source
The Oncologist, EarlyView., 2021 Abstract Background LIBRETTO‐001 is an ongoing, global, open‐label, phase I/II study of selpercatinib in patients with advanced or metastatic solid tumors. We report interim patient‐reported outcomes in patients with RET fusion–positive non‐small cell lung cancer (NSCLC).
Anna Minchom +11 more
wiley +1 more source
Noninvasive Disease Diagnostics: The Swiss Contribution Highlights to Breath Analysis Research
Helvetica Chimica Acta, EarlyView.Breath analysis networks across Switzerland linking health monitoring, clinical applications, population studies, and data‐driven public health decisions. ABSTRACT To celebrate the 125th anniversary of the Swiss Chemical Society, we present a review and perspective to highlight the recent research in breath analysis that has been conducted in ...
Stefan James Swift +6 more
wiley +1 more source